Compare ANF & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANF | APGE |
|---|---|---|
| Founded | 1892 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.7B |
| IPO Year | 1996 | 2023 |
| Metric | ANF | APGE |
|---|---|---|
| Price | $83.95 | $72.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 11 |
| Target Price | ★ $122.00 | $102.40 |
| AVG Volume (30 Days) | ★ 1.5M | 780.2K |
| Earning Date | 06-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.86 | N/A |
| EPS | ★ 6.83 | N/A |
| Revenue | ★ $4,948,587,000.00 | N/A |
| Revenue This Year | $5.24 | N/A |
| Revenue Next Year | $3.41 | N/A |
| P/E Ratio | $12.36 | ★ N/A |
| Revenue Growth | ★ 15.60 | N/A |
| 52 Week Low | $65.40 | $26.20 |
| 52 Week High | $133.11 | $84.56 |
| Indicator | ANF | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 31.16 | 54.53 |
| Support Level | $74.66 | $35.24 |
| Resistance Level | $84.01 | $80.99 |
| Average True Range (ATR) | 4.52 | 3.39 |
| MACD | -0.86 | 0.59 |
| Stochastic Oscillator | 4.42 | 76.76 |
Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumers through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Majority stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.